https://www.clinicaltrialsarena.com/news/newsalcobra-enrols-first-patient-in-phase-iii-trial-of-mdx-to-treat-adhd-patients-4199411/
Israel-based biopharmaceutical firm Alcobra has initiated patient enrolment in a Phase III clinical trial of its proprietary drug candidate Metadoxine Extended...
phase iii trialalcobrafirstpatientmdx